Drug Shortage Report for NAT-ERLOTINIB

Last updated on 2022-01-17 History
Report ID 129536
Drug Identification Number 02483912
Brand name NAT-ERLOTINIB
Common or Proper name Erlotinib Hydrochloride Tablets
Company Name NATCO PHARMA (CANADA) INC
Market Status MARKETED
Active Ingredient(s) ERLOTINIB
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size Bottle of 30's
ATC code L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-12-01
Actual start date 2020-12-01
Estimated end date 2022-06-30
Actual end date
Shortage status Actual shortage
Updated date 2022-01-17
Company comments Long Term Backorder
Health Canada comments
Tier 3 Status No
Contact Address 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5N 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-01-17 French Compare
v3 2022-01-17 English Compare
v2 2020-12-03 French Compare
v1 2020-12-03 English Compare

Showing 1 to 4 of 4